ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,381.35
0.33%
Dow Jones
39,387.76
0.85%
Gold vs US Dollar
2,354.01
0.31%
Brent Oil
84.255
0.36%
Bitcoin
62,786.70
-0.42%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE
  6. Churchill Capital Corp VII (CVII)

  7. Churchill Capital Corp VII (CVII) News

Churchill Capital Corp VII (CVII)

Churchill Capital Corp VII
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:CVII
DateTimeSourceHeadlineSymbolCompany
03/05/202422:25Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:CVIIChurchill Capital Corp VII
22/03/202412:46Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNYSE:CVIIChurchill Capital Corp VII
22/03/202412:45Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNYSE:CVIIChurchill Capital Corp VII
22/03/202412:30PR Newswire (US)Special Meeting of Churchill Capital Corp VII Stockholders to Approve Business Combination with CorpAcq and Warrant Holder Meeting to Approve Warrant Amendment Scheduled for May 21, 2024NYSE:CVIIChurchill Capital Corp VII
04/03/202413:51Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNYSE:CVIIChurchill Capital Corp VII
04/03/202413:51Edgar (US Regulatory)Form 8-K - Current reportNYSE:CVIIChurchill Capital Corp VII
12/02/202421:03Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNYSE:CVIIChurchill Capital Corp VII
12/02/202421:01Edgar (US Regulatory)Form 8-K - Current reportNYSE:CVIIChurchill Capital Corp VII
12/02/202414:19Edgar (US Regulatory)Form 8-K - Current reportNYSE:CVIIChurchill Capital Corp VII
08/02/202414:14Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNYSE:CVIIChurchill Capital Corp VII
08/02/202413:51Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNYSE:CVIIChurchill Capital Corp VII
08/02/202402:47Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNYSE:CVIIChurchill Capital Corp VII
02/02/202421:36Edgar (US Regulatory)Form CERT - Certification by an exchange approving securities for listingNYSE:CVIIChurchill Capital Corp VII
02/02/202421:04Edgar (US Regulatory)Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securitiesNYSE:CVIIChurchill Capital Corp VII
02/02/202421:01Edgar (US Regulatory)Form 8-A12B - Registration of securities [Section 12(b)]NYSE:CVIIChurchill Capital Corp VII
30/01/202422:41PR Newswire (US)Churchill Capital Corp VII Announces Continuation of $1,000,000 Monthly Sponsor ContributionNYSE:CVIIChurchill Capital Corp VII
25/01/202414:25Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNYSE:CVIIChurchill Capital Corp VII
23/01/202422:30PR Newswire (US)Churchill Capital Corp VII Announces Intention to Transfer Listing to NasdaqNYSE:CVIIChurchill Capital Corp VII
22/01/202418:08Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNYSE:CVIIChurchill Capital Corp VII
22/01/202415:36Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNYSE:CVIIChurchill Capital Corp VII
22/01/202413:30PR Newswire (US)CorpAcq Reaffirms 2023 Guidance and Provides Business and Refinancing UpdateNYSE:CVIIChurchill Capital Corp VII
26/12/202321:19Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNYSE:CVIIChurchill Capital Corp VII
26/12/202321:11Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNYSE:CVIIChurchill Capital Corp VII
26/12/202321:07Edgar (US Regulatory)Form 8-K - Current reportNYSE:CVIIChurchill Capital Corp VII
22/12/202321:02Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNYSE:CVIIChurchill Capital Corp VII
20/12/202311:08Edgar (US Regulatory)Form 8-K - Current reportNYSE:CVIIChurchill Capital Corp VII
17/11/202312:26Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNYSE:CVIIChurchill Capital Corp VII
17/11/202312:25Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNYSE:CVIIChurchill Capital Corp VII
17/11/202312:24Edgar (US Regulatory)Form 8-K - Current reportNYSE:CVIIChurchill Capital Corp VII
17/11/202311:43PR Newswire (US)CorpAcq and Churchill Capital Corp VII Announce Filing of Registration Statement on Form F-4 in Connection with Proposed Business Combination and CorpAcq's First Half 2023 ResultsNYSE:CVIIChurchill Capital Corp VII
 Showing the most relevant articles for your search:NYSE:CVII

Your Recent History

LSE
GKP
Gulf Keystone Petroleum
LSE
ITM
Itm Power
LSE
SAR
Sareum
LSE
TYM
Tertiary Minerals
LSE
GDR
Genedrive
LSE
SYME
Supply@me Capital
LSE
AGL
Angle
LSE
PEN
Pennant
LSE
TERN
Tern
NYSE
SPCE
Virgin Galactic
LSE
EMG
Man
LSE
TAVI
Tavistock Investments
LSE
CAD
Cadogan Energy Solutions
LSE
DGI
Dg Innovate
LSE
GDP
Goldplat
LSE
RE.B
R.e.a Hlds 9%pf
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved